Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04831398 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effects of Acute Melatonin Supplementation on Cardiovascular Responses to Sympathetic Activation

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v10
  2. Primary completion date: Sep 2024 to Nov 2026
    • Study completion date: Dec 2024 to Dec 2026
    v9
  3. Primary completion date: May 1, 2024 to Sep 2024
    • Study completion date: May 1, 2024 to Dec 2024
    v8
  4. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v7
  5. Primary and study completion dates: May 1, 2023 to May 1, 2024
    • Start date: Jul 1, 2022 to Jan 1, 2023
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Start date: May 1, 2022 to Jul 1, 2022
    • Interventions: Control (Other), Placebo (Other), melatonin (Dietary Supplement) to Placebo (Other), melatonin (Dietary Supplement)
    • Study description shortened, about 11 words
    • Study arms: 3 to 2
    v5
  2. Start date: Jan 1, 2022 to May 1, 2022v4
  3. Re-verified, no change to tracked fieldsv3
  4. Start date: May 1, 2021 to Jan 1, 2022v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
the purpose of this experiment is to determine if acute melatonin supplementation alters central and peripheral cardiovascular responses to a cold pressor test at rest and during dynamic exercise.
Trial Details
NCT Number NCT04831398
Lead Sponsor University of Oklahoma
Conditions
(from sponsor)		 Healthy
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov